Y
Yong Concrete PCL
SET:YONG
Yong Concrete PCL
SET:YONG
Price:
0.73
THB
1.39%
Market Cap:
฿496.4m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Y
|
Yong Concrete PCL
SET:YONG
|
TH |
|
F
|
Fortum Oyj
OMXH:FORTUM
|
FI |
|
D
|
DCX Systems Ltd
NSE:DCXINDIA
|
IN |
|
Sarepta Therapeutics Inc
NASDAQ:SRPT
|
US |
|
Regis Healthcare Ltd
ASX:REG
|
AU |
|
Check Cap Ltd
NASDAQ:CHEK
|
IL |
|
S
|
South Jersey Industries Inc
F:J4S
|
US |
|
Z
|
Zhejiang Aokang Shoes Co Ltd
SSE:603001
|
CN |
|
Velan Inc
TSX:VLN
|
CA |
|
Euro Panel Products Ltd
NSE:EUROBOND
|
IN |
|
Keystone Law Group PLC
LSE:KEYS
|
UK |
|
A
|
Anhui Huaren Health Pharmaceutical Co Ltd
SZSE:301408
|
CN |
Balance Sheet
Balance Sheet Decomposition
Yong Concrete PCL
Yong Concrete PCL
Balance Sheet Decomposition is not available for
Yong Concrete PCL
Yong Concrete PCL
Balance Sheet
Yong Concrete PCL
Yong Concrete PCL
Currency: THB
| Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | Dec-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Cash & Cash Equivalents |
11
|
3
|
8
|
2
|
34
|
154
|
51
|
46
|
64
|
|
| Cash Equivalents |
11
|
3
|
8
|
2
|
34
|
154
|
51
|
46
|
64
|
|
| Total Receivables |
215
|
211
|
207
|
151
|
139
|
174
|
185
|
167
|
185
|
|
| Accounts Receivables |
215
|
211
|
207
|
151
|
139
|
174
|
185
|
167
|
185
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Inventory |
124
|
125
|
77
|
91
|
154
|
126
|
148
|
118
|
95
|
|
| Other Current Assets |
1
|
1
|
6
|
5
|
5
|
4
|
1
|
1
|
1
|
|
| Total Current Assets |
351
|
340
|
298
|
250
|
333
|
459
|
385
|
331
|
344
|
|
| PP&E Net |
807
|
799
|
732
|
728
|
704
|
782
|
844
|
845
|
886
|
|
| Intangible Assets |
4
|
5
|
5
|
4
|
3
|
3
|
2
|
2
|
1
|
|
| Note Receivable |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Long-Term Investments |
62
|
62
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Long-Term Assets |
24
|
37
|
52
|
59
|
63
|
90
|
67
|
56
|
56
|
|
| Total Assets |
1 248
N/A
|
1 242
-1%
|
1 086
-13%
|
1 041
-4%
|
1 103
+6%
|
1 333
+21%
|
1 298
-3%
|
1 233
-5%
|
1 287
+4%
|
|
| Liabilities | ||||||||||
| Accounts Payable |
128
|
130
|
89
|
102
|
94
|
85
|
112
|
89
|
96
|
|
| Accrued Liabilities |
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Short-Term Debt |
231
|
207
|
142
|
161
|
71
|
96
|
74
|
96
|
88
|
|
| Current Portion of Long-Term Debt |
66
|
72
|
97
|
76
|
124
|
95
|
80
|
36
|
34
|
|
| Other Current Liabilities |
33
|
20
|
53
|
14
|
24
|
23
|
38
|
12
|
22
|
|
| Total Current Liabilities |
459
|
430
|
380
|
354
|
313
|
300
|
304
|
233
|
241
|
|
| Long-Term Debt |
265
|
217
|
270
|
297
|
327
|
165
|
50
|
45
|
104
|
|
| Deferred Income Tax |
0
|
0
|
0
|
0
|
0
|
0
|
1
|
14
|
17
|
|
| Other Liabilities |
30
|
21
|
20
|
26
|
29
|
32
|
32
|
36
|
42
|
|
| Total Liabilities |
754
N/A
|
668
-11%
|
670
+0%
|
677
+1%
|
669
-1%
|
497
-26%
|
388
-22%
|
329
-15%
|
403
+23%
|
|
| Equity | ||||||||||
| Common Stock |
250
|
250
|
250
|
250
|
250
|
340
|
340
|
340
|
340
|
|
| Retained Earnings |
244
|
324
|
166
|
115
|
184
|
150
|
224
|
218
|
198
|
|
| Additional Paid In Capital |
0
|
0
|
0
|
0
|
0
|
346
|
346
|
346
|
346
|
|
| Total Equity |
494
N/A
|
574
+16%
|
416
-28%
|
365
-12%
|
434
+19%
|
836
+93%
|
910
+9%
|
904
-1%
|
884
-2%
|
|
| Total Liabilities & Equity |
1 248
N/A
|
1 242
-1%
|
1 086
-13%
|
1 041
-4%
|
1 103
+6%
|
1 333
+21%
|
1 298
-3%
|
1 233
-5%
|
1 287
+4%
|
|
| Shares Outstanding | ||||||||||
| Common Shares Outstanding |
680
|
680
|
680
|
680
|
680
|
680
|
680
|
680
|
680
|
|
Switch to:
Switch to:
See Also
Discover More
